Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Tiersten
Gynecologic Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Medical Center at Irvine-Orange Campus
Orange, California, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- New York University Langone Medical Center
New York, New York, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Lake University Ireland Cancer Center
Mentor, Ohio, United States
- Cancer Care Associates-Midtown
Tulsa, Oklahoma, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Jul 2010
- Completion
- —
- Last update posted
- 31 Dec 2014
- Registered enrollment
- 43
- Registry id
- NCT00352300
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.